206. 脆弱Ｘ症候群 Fragile X syndrome Clinical trials / Disease details

臨床試験数 : 108 / 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05418049 (ClinicalTrials.gov)	September 8, 2022	31/5/2022	Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge	Evaluating the Neurophysiologic and Clinical Effects of Single-Dose Baclofen, Roflumilast, Memantine ...	Fragile X Syndrome	Drug: Baclofen;Drug: Memantine;Drug: Roflumilast;Drug: Placebo	Children's Hospital Medical Center, Cincinnati	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Recruiting	18 Years	45 Years	All	45	Phase 2	United States
2	NCT02998151 (ClinicalTrials.gov)	January 2016	1/12/2016	Neurophysiological and Acute Pharmacological Studies in FXS Patients	Neurophysiological and Acute Pharmacological Studies in FXS Patients	Fragile X Syndrome	Drug: Acamprosate;Drug: Lovastatin;Drug: Minocycline;Drug: Placebo;Drug: Baclofen	Children's Hospital Medical Center, Cincinnati	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Completed	15 Years	55 Years	All	29	Early Phase 1	United States

First Previous1Next Last